181
Prevention of Coronary Heart Disease in Morbidly Obese Patients
Condition(s): Morbid Obesity; Hypertension; Type 2 DM; Obstructive Sleep Apnea; Osteoarthrosis Last Updated: February 28, 2008Recruiting
324 Clinical Trials for: ApoB, Page 10 of 17
Hide Studies Not Seeking New Volunteers
182
Study of the Efficacy and Safety of REGN727 (SAR236553) in Combination With Other Lipid-modifying Treatments (LMT)
Condition(s): Hypercholesterolemia Last Updated: March 18, 2013Recruiting
183
Study of REGN727 (SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT)
Condition(s): Hypercholesterolemia Last Updated: November 14, 2012Recruiting
184
Effect of Cheese on Cardiovascular Risk
Condition(s): Hyperlipidemia Last Updated: February 13, 2013Recruiting
185
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
Condition(s): Hypertriglyceridemia; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemia Type IIb; Hyperlipidemia Last Updated: November 30, 2010Completed
186
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Condition(s): Type 2 Diabetes Mellitus Last Updated: July 24, 2012Active, not recruiting
187
Low Fat Milk Intake and Cardio Vascular Risk (CVR) Indicators in Children
Condition(s): Cardiovascular Diseases Last Updated: June 24, 2011Completed
188
HIV Antiretroviral Drugs and Metabolism
Condition(s): HIV Infections Last Updated: March 15, 2011Recruiting
189
A Study to Determine if REGN727(SAR236553) Will Have an Effect of Circulating Lipids in Patients With Gain-of-function (GOF) Mutations in Their PCSK9 Gene
Condition(s): Hypercholesterolemia Last Updated: January 23, 2013Active, not recruiting
190
Body Fat Distribution and Fat Metabolism
Condition(s): Obesity; Metabolic Disease Last Updated: April 4, 2008Completed
191
Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth"
Condition(s): Metabolic Syndrome; Type 2 Diabetes; Cardiovascular Disease; Abdominal Obesity Last Updated: January 3, 2013Completed
192
A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
Condition(s): Coronary Heart Disease Last Updated: September 14, 2012Completed
193
Atorvastatin Three Year Pediatric Study
Condition(s): Familial Hypercholesterolemia Last Updated: April 29, 2013Recruiting
194
Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease
Condition(s): Cardiovascular Diseases Last Updated: November 15, 2011Completed
195
Optimal Dietary Fat Pattern to Prevent Cardiovascular Disease Among Type 2 Diabetes
Condition(s): Type 2 Diabetes Mellitus Last Updated: April 26, 2007Completed
196
Fructose-induced Intestinal de Novo Lipogenesis
Condition(s): Obesity Last Updated: February 13, 2013Recruiting
197
A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin
Condition(s): Hypercholesterolemia Last Updated: September 24, 2007Terminated
198
Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients
Condition(s): Hypercholesterolemia Last Updated: September 7, 2012Recruiting
199
Controlled Outcome Evaluations of a Daily Physical Activity Intervention for Individuals With Type 2 Diabetes
Condition(s): Type 2 Diabetes Last Updated: May 18, 2009Completed
200
Effect of Conjugated Linoleic Acid Alone and in Conjunction With Vitamin E in Patients With Type 2 Diabetes Mellitus
Condition(s): Type 2 Diabetes Mellitus Last Updated: June 14, 2011Completed
